glp-1 agonists and inflammation Advances in receptor for pain treatment their future potential GLP-1 Agonists in Cardiovascular Diseases:
Description
Daily injected, Saxenda, a first-generation GLP-1, was the first drug approved for this
Gut microbial signatures for glycemic responses of GLP-1 receptor agonists in type 2 diabetic patients: A pilot study
The results, despite optimistic interpretation by the sponsors, showed little if any cardiovascular benefit that could not have been a consequence of glucose lowering with some suggestion that the net effects of some agents might be harmful on vascular disease (6)
"Tirzepatide Once Weekly for the Treatment of Obesity"
Considerations for long-term use GLP-1 drugs for weight loss aren't a quick fix
Who it helps: This primarily benefits people with high-deductible plans or those paying coinsurance based on the sticker price.
